Press Releases September 30, 2026 04:05 PM

QCR Holdings, Inc. to Report Third Quarter 2026 Financial Results

QCR Holdings Announces Third Quarter 2026 Earnings Release and Conference Call

By Ajmal Hussain
Share
Twitter Reddit Facebook LinkedIn
QCRH

QCR Holdings, Inc., a multi-bank holding company providing commercial and consumer banking services in the Midwest, will release its financial results for Q3 2026 on October 20, 2026. The company will host a conference call and webcast on October 21 to discuss the results with shareholders and analysts.

QCR Holdings, Inc. to Report Third Quarter 2026 Financial Results
QCRH
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • QCR Holdings to announce Q3 2026 earnings after market close on October 20, 2026.
  • Conference call and webcast scheduled for October 21, 2026, for stakeholders to discuss results.
  • The company operates multiple banks in Iowa, Missouri, and Illinois with $9.5 billion in assets as of June 30, 2026.

MOLINE, Ill., Sept. 30, 2026 (GLOBE NEWSWIRE) -- QCR Holdings, Inc. (NASDAQ: QCRH) (“QCRH” or the “Company”) announced today that its third quarter ended September 30, 2026, financial results will be released after the market closes on Tuesday, October 20, 2026. The Company will host a conference call and webcast the next day, Wednesday, October 21, 2026, at 10:00 a.m. Central Time to discuss the results. Shareholders, analysts, and other interested parties are invited to join.

Teleconference
Dial-in information for the call is 888-346-9286 (international 412-317-5253). Participants should request to join the QCR Holdings, Inc. call. The event will be archived and available for replay through October 28, 2026. The replay access information is 855-669-9658 (international 412-317-0088); access code 5670385.

Webcast
A webcast of the teleconference can be accessed at the Company’s News and Events page at www.qcrh.com. An archived version of the webcast will be available at the same location shortly after the live event has ended.

About Us
QCR Holdings, Inc., headquartered in Moline, Illinois, is a relationship-driven, multi-bank holding company serving the Quad Cities, Cedar Rapids, Cedar Valley, Des Moines/Ankeny and Springfield communities through its wholly owned subsidiary banks. The banks provide full-service commercial and consumer banking and trust and wealth management services. Quad City Bank & Trust Company, based in Bettendorf, Iowa, commenced operations in 1994, Cedar Rapids Bank & Trust Company, based in Cedar Rapids, Iowa, commenced operations in 2001, Community State Bank, based in Ankeny, Iowa, was acquired by the Company in 2016, and Guaranty Bank, based in Springfield, Missouri, was acquired by the Company in 2018. Additionally, the Company serves the Waterloo/Cedar Falls, Iowa community through Community Bank & Trust, a division of Cedar Rapids Bank & Trust Company. The Company has 35 locations in Iowa, Missouri, and Illinois. As of June 30, 2026, the Company had $9.5 billion in assets, $7.0 billion in loans and $7.4 billion in deposits. For additional information, please visit the Company’s website at www.qcrh.com.

Contact
Doug Neumann
VP, Investor Relations
(309) 743-7753
[email protected]                                                                 


Risks

  • Earnings results may not meet market expectations, potentially impacting stock performance.
  • Economic conditions in the Midwest banking sectors could affect loan performance and deposit growth.
  • Regulatory changes in the banking industry could impact operational costs and compliance requirements.

More from Press Releases

Silvaco CEO Dr. Walden “Wally” Rhines Inducted into the National Academy of Engineering Oct 2, 2026 Ultragenyx Announces Marketing Authorisation Application (MAA) Submission to the European Medicines Agency (EMA) for the First Investigational Gene Therapy for MPS IIIA (Sanfilippo Syndrome Type A) Oct 2, 2026 Moderna, Inc. to Join the Nasdaq-100 Index® Beginning October 9, 2026 Oct 1, 2026 New Drug Application Submission Initiated for Zipalertinib Plus Chemotherapy in First-Line EGFR Exon 20 Insertion Mutation NSCLC for Review Under FDA Real-Time Oncology Review Program Oct 1, 2026 FEMSA Schedules Conference Call to Discuss Third Quarter Financial Results Oct 1, 2026